Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) CEO Christopher Anzalone sold 12,000 shares of the company's stock on December 20, 2023, according to a recent SEC filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Arrowhead Pharmaceuticals Inc CEO Christopher Anzalone Sells 12,000 Shares